About this episode
In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options.
C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.
Get every episode summarized
Each time Inflection Point publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Inflection Point
The electric innovations that brought lithium-ion batteries online
Inflection Point
The ancient, 'juicy' origins of antibiotic resistance
Inflection Point
The era-spanning epiphanies that enabled gene editing
Inflection Point
Vote for Inflection Point in the Signal Awards!
Inflection Point